4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway

Toxicology

Volumn 304, Issue , 2013, Pages 13-20

  Lee, Hye Rim ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Breast cancer; Cathepsins; Estrogen receptor; Octylphenol

Indexed keywords

4 TERT OCTYLPHENOL; CATHEPSIN; CATHEPSIN B; CATHEPSIN D; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CATHEPSIN B; CATHEPSIN D; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PHENOLS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84871582083     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.10.012     Document Type: Article

References (52)

1. An B.S., Choi K.C., Kang S.K., Hwang W.S., Jeung E.B. Novel calbindin-D(9k) protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats. Reprod. Toxicol. 2003, 17:311-319.
2. Andruska N., Mao C., Cherian M., Zhang C., Shapiro D.J. Evaluation of a luciferase-based reporter assay as a screen for inhibitors of estrogen-ERalpha-induced proliferation of breast cancer cells. J. Biomol. Screen. 2012, 17:921-932.
3. Bretschneider N., Kangaspeska S., Seifert M., Reid G., Gannon F., Denger S. E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elements. Mol. Oncol. 2008, 2:182-190.
4. Chai Y., Wu W., Zhou C., Zhou J. The potential prognostic value of cathepsin D protein in serous ovarian cancer. Arch. Gynecol. Obstet. 2012, 286:465-471.
5. Chan H.S., Chang S.J., Wang T.Y., Ko H.J., Lin Y.C., Lin K.T., Chang K.M., Chuang Y.J. Serine protease PRSS23 is upregulated by estrogen receptor alpha and associated with proliferation of breast cancer cells. PLoS ONE 2012, 7:e30397.
6. Chipman S.D., Oldham F.B., Pezzoni G., Singer J.W. Biological and clinical characterization of paclitaxel polyglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate. Int. J. Nanomed. 2006, 1:375-383.
7. Choi B.D., Jeong S.J., Wang G., Park J.J., Lim D.S., Kim B.H., Cho Y.I., Kim C.S., Jeong M.J. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. Int. J. Mol. Med. 2011, 28:527-534.
8. Choi K.C., Jeung E.B. The biomarker and endocrine disruptors in mammals. J. Reprod. Dev. 2003, 49:337-345.
9. Devetzi M., Scorilas A., Tsiambas E., Sameni M., Fotiou S., Sloane B.F., Talieri M. Cathepsin B protein levels in endometrial cancer: potential value as a tumour biomarker. Gynecol. Oncol. 2009, 112:531-536.
10. Dian D., Vrekoussis T., Shabani N., Mylonas I., Kuhn C., Schindlbeck C., Navrozoglou I., Friese K., Makrigiannakis A., Jeschke U. Expression of cathepsin-D in primary breast cancer and corresponding local recurrence or metastasis: an immunohistochemical study. Anticancer Res. 2012, 32:901-905.
11. Elie B.T., Gocheva V., Shree T., Dalrymple S.A., Holsinger L.J., Joyce J.A. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie 2010, 92:1618-1624.
12. Gil-Henn H., Patsialou A., Wang Y., Warren M.S., Condeelis J.S., Koleske A.J. Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo. Oncogene 2012, 10.1038/onc.2012.284.
13. Gocheva V., Wang H.W., Gadea B.B., Shree T., Hunter K.E., Garfall A.L., Berman T., Joyce J.A. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010, 24:241-255.
14. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
15. Hamelin G., Charest-Tardif G., Krishnan K., Cyr D., Charbonneau M., Devine P.J., Haddad S., Cooke G.M., Schrader T., Tardif R. Toxicokinetics of p-tert-octylphenol in male and female Sprague-Dawley rats after intravenous, oral, or subcutaneous exposures. J. Toxicol. Environ. Health A 2009, 72:541-550.
16. Hamelin G., Haddad S., Krishnan K., Tardif R. Physiologically based modeling of p-tert-octylphenol kinetics following intravenous, oral or subcutaneous exposure in male and female Sprague-Dawley rats. J. Appl. Toxicol. 2010, 30:437-449.
17. Hwang K.A., Park S.H., Yi B.R., Choi K.C. Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab. Anim. Res. 2011, 27:99-107.
18. Jing X., Bing S., Xiaoyan W., Xiaojie S., Yongning W. A study on bisphenol A, nonylphenol, and octylphenol in human urine amples detected by SPE-UPLC-MS. Biomed. Environ. Sci. 2011, 24:40-46.
19. Jung E.M., An B.S., Choi K.C., Jeung E.B. Potential estrogenic activity of triclosan in the uterus of immature rats and rat pituitary GH3 cells. Toxicol. Lett. 2011, 208:142-148.
20. Jung E.M., An B.S., Yang H., Choi K.C., Jeung E.B. Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors. Int. J. Environ. Res. Public Health 2012, 9:698-711.
21. Kang N.H., Hwang K.A., Kim T.H., Hyun S.H., Jeung E.B., Choi K.C. Induced growth of BG-1 ovarian cancer cells by 17beta-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression. Mol. Med. Rep. 2012, 6:151-156.
22. Kanoh Y., Ohtani H., Egawa S., Baba S., Akahoshi T. Changes of proteases and proteinase inhibitors in androgen-dependent advanced prostate cancer patients with alpha2-macroglobulin deficiency. Clin. Lab. 2012, 58:217-225.
23. Kim J.T., Song E.Y., Chung K.S., Kang M.A., Kim J.W., Kim S.J., Yeom Y.I., Kim J.H., Kim K.H., Lee H.G. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 2011, 117:2608-2619.
24. Kim Y.R., Jung E.M., Choi K.C., Jeung E.B. Synergistic effects of octylphenol and isobutyl paraben on the expression of calbindin-D(9)k in GH3 rat pituitary cells. Int. J. Mol. Med. 2011, 29:294-302.
25. Knudsen E.S., Ertel A., Davicioni E., Kline J., Schwartz G.F., Witkiewicz A.K. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res. Treat. 2011, 133:1009-1024.
26. Lee H.R., Hwang K.A., Park M.A., Yi B.R., Jeung E.B., Choi K.C. Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. Int. J. Mol. Med. 2012, 29:883-890.
27. Lee H.R., Kim T.H., Choi K.C. Functions and physiological roles of two types of estrogen receptors, ERalpha and ERbeta, identified by estrogen receptor knockout mouse. Lab. Anim. Res. 2012, 28:71-76.
28. Li C., Chen L., Wang J., Zhang L., Tang P., Zhai S., Guo W., Yu N., Zhao L., Liu M., Yang S. Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer. Oncol. Rep. 2011, 26:869-875.
29. Lodillinsky C., Rodriguez V., Vauthay L., Sandes E., Casabe A., Eijan A.M. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer. J. Urol. 2009, 182:749-755.
30. Masson O., Prebois C., Derocq D., Meulle A., Dray C., Daviaud D., Quilliot D., Valet P., Muller C., Liaudet-Coopman E. Cathepsin-D, a key protease in breast cancer, is up-regulated in obese mouse and human adipose tissue, and controls adipogenesis. PLoS ONE 2011, 6:e16452.
31. Molineaux S.M. Molecular pathways: targeting proteasomal protein degradation in cancer. Clin. Cancer Res. 2011, 18:15-20.
32. Nouh M.A., Mohamed M.M., El-Shinawi M., Shaalan M.A., Cavallo-Medved D., Khaled H.M., Sloane B.F. Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J. Transl. Med. 2011, 9:1.
33. Park M.A., Hwang K.A., Choi K.C. Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: do they have tumorigenic or anti-tumorigenic property?. Lab. Anim. Res. 2012, 27:265-273.
34. Park M.A., Hwang K.A., Lee H.R., Yi B.R., Jeung E.B., Choi K.C. Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes. Mol. Med. Rep. 2012, 5:761-766.
35. Pisapia L., Del Pozzo G., Barba P., Caputo L., Mita L., Viggiano E., Russo G.L., Nicolucci C., Rossi S., Bencivenga U., Mita D.G., Diano N. Effects of some endocrine disruptors on cell cycle progression and murine dendritic cell differentiation. Gen. Comp. Endocrinol. 2012, 178:54-63.
36. Ricciardelli C., Frewin K.M., Tan Ide A., Williams E.D., Opeskin K., Pritchard M.A., Ingman W.V., Russell D.L. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. Am. J. Pathol. 2011, 179:3075-3085.
37. Sevenich L., Werner F., Gajda M., Schurigt U., Sieber C., Muller S., Follo M., Peters C., Reinheckel T. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene 2010, 30:54-64.
38. Shaffer S.A., Baker-Lee C., Kennedy J., Lai M.S., de Vries P., Buhler K., Singer J.W. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother. Pharmacol. 2007, 59:537-548.
39. Skrzypczak M., Springwald A., Lattrich C., Haring J., Schuler S., Ortmann O., Treeck O. Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes. Cancer Invest. 2012, 30:398-403.
40. Subramaniyam D., Hollander C., Westin U., Erjefalt J., Stevens T., Janciauskiene S. Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis. Respirology 2011, 16:300-307.
41. Uhlmann M.E., Georgieva M., Sill M., Linnemann U., Berger M.R. Prognostic value of tumor progression-related gene expression in colorectal cancer patients. J. Cancer Res. Clin. Oncol. 2012, 138:1631-1640.
42. Vargas A.C., Reed A.E., Waddell N., Lane A., Reid L.E., Smart C.E., Cocciardi S., da Silva L., Song S., Chenevix-Trench G., Simpson P.T., Lakhani S.R. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res. Treat. 2012, 135:153-165.
43. Victor B.C., Anbalagan A., Mohamed M.M., Sloane B.F., Cavallo-Medved D. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Res. 2011, 13:R115.
44. Wang J., Chen L., Li Y., Guan X.Y. Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS ONE 2011, 6:e24967.
45. Wen J., Nikitakis N.G., Chaisuparat R., Greenwell-Wild T., Gliozzi M., Jin W., Adli A., Moutsopoulos N., Wu T., Warburton G., Wahl S.M. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. Am. J. Pathol. 2011, 178:2866-2878.
46. Withana N.P., Blum G., Sameni M., Slaney C., Anbalagan A., Olive M.B., Bidwell B.N., Edgington L., Wang L., Moin K., Sloane B.F., Anderson R.L., Bogyo M.S., Parker B.S. Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res. 2012, 72:1199-1209.
47. Wu D., Wang H., Li Z., Wang L., Zheng F., Jiang J., Gao Y., Zhong H., Huang Y., Suo Z. Cathepsin B may be a potential biomarker in cervical cancer. Histol. Histopathol. 2011, 27:79-87.
48. Wu S.M., Huang Y.H., Yeh C.T., Tsai M.M., Liao C.H., Cheng W.L., Chen W.J., Lin K.H. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011, 30:2057-2069.
49. Yhee J.Y., Kim S.A., Koo H., Son S., Ryu J.H., Youn I.C., Choi K., Kwon I.C., Kim K. Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes. Theranostics 2012, 2:179-189.
50. Zhang C., Sun J.B., Liu D.C., Cui Y.Q., Liu S., Sun H.C. Preliminary research on the pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice. Chin. Med. J. (Engl.) 2009, 122:2489-2496.
51. Zhang W., Yang H.C., Wang Q., Yang Z.J., Chen H., Wang S.M., Pan Z.M., Tang B.J., Li Q.Q., Li L. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis. Anticancer Res. 2011, 31:3423-3428.
52. Zhang Z., Feng Y., Gao P., Wang C., Ren N. Occurrence and removal efficiencies of eight EDCs and estrogenicity in a STP. J. Environ. Monit. 2011, 13:1366-1373.